Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Recombinant derivative of C3 transferase

EU orphan designation number: EU/3/08/563   
Active ingredient: Recombinant derivative of C3 transferase
Indication: Treatment of traumatic spinal cord injury
Sponsor: Vertex Pharmaceuticals (Ireland) Limited
28-32 Pembroke Street Upper, Dublin 2, D02 EK84, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
9/09/2008 Orphan designation EMEA/OD/012/08 (2008)5024 of 5/09/2008
23/01/2014 Change of name and/or address of sponsor
27/01/2015 Transfer of orphan designation EMA/OD/012/08/T/01 (2015)415 of 23/01/2015
17/01/2017 Change of name and/or address of sponsor
13/03/2017 Transfer of orphan designation EMA/OD/012/08/T/02 (2017)1710 of 9/03/2017
8/03/2019 Transfer of orphan designation EMA/OD/0000004115 (2019)1952 of 6/03/2019